In uninfected household contacts of patients with COVID-19, REGEN-COV reduced symptomatic COVID-19 at 28 d

Darren Lau; Lynora Saxinger

doi:10.7326/J21-0008

In uninfected household contacts of patients with COVID-19, REGEN-COV reduced symptomatic COVID-19 at 28 d

Ann Intern Med. 2022 Jan;175(1):JC5. doi: 10.7326/J21-0008. Epub 2022 Jan 4.

Authors

Darren Lau¹, Lynora Saxinger¹

Affiliation

¹ University of Alberta, Edmonton, Alberta, Canada (D.L., L.S.).

PMID: 34978854
DOI: 10.7326/J21-0008

Abstract

O'Brien MP, Forleo-Neto E, Musser BJ, et al. Subcutaneous REGEN-COV antibody combination to prevent Covid-19. N Engl J Med. 2021;385:1184-95. 34347950.

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
COVID-19*
Drug Combinations
Humans
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
Drug Combinations
casirivimab and imdevimab drug combination